TradingKey

關於 Artivion Inc 公司

Artivion, Inc. 是一家醫療器械公司，從事製造、加工和分銷用於治療主動脈疾病、心臟瓣膜疾病、主動脈瘤和主動脈夾層患者的心臟和血管外科手術的醫療器械和可植入人體組織。該公司的部門包括醫療器械和保存服務。醫療器械部門包括主動脈支架移植物、手術密封劑和 On-X 的銷售。保存服務部門包括保存心臟和血管可植入人體組織的服務。該公司有四個產品系列：主動脈支架移植物、手術密封劑、On-X 機械心臟瓣膜和相關手術產品以及可植入心臟和血管人體組織。主動脈支架移植物包括主動脈弓支架移植物、腹部支架移植物和合成血管移植物。手術密封劑包括 BioGlue 手術粘合劑產品。該公司還銷售或分銷 PhotoFix 牛手術貼片。

公司簡介

公司代碼AORT

公司名稱Artivion Inc

上市日期Feb 12, 1993

CEOMr. James Patrick (Pat) Mackin

員工數量1600

證券類型Ordinary Share

年結日Feb 12

公司地址1655 Roberts Boulevard N W

城市KENNESAW

上市交易所NYSE Consolidated

國家United States of America

郵編30144

電話17704193355

網址https://artivion.com/

公司代碼AORT

上市日期Feb 12, 1993

CEOMr. James Patrick (Pat) Mackin

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. John E. Davis

Senior Vice President - Global Sales and Marketing

188.49K

+7.55%

Mr. Daniel J. Bevevino

Independent Director

150.06K

+4.40%

Mr. Thomas F. Ackerman

Independent Director

149.90K

+4.41%

Ms. Amy D. Horton, CPA

Chief Accounting Officer, Vice President

142.38K

+6.92%

Mr. Jon W. Salveson

Independent Director

129.84K

+5.12%

Mr. Lance A. Berry, CPA

Chief Financial Officer, Executive Vice President - Finance

121.36K

+10.09%

Mr. James W. Bullock

Independent Director

68.65K

+10.15%

Mr. Jeffrey H. (Jeff) Burbank

Lead Independent Director

53.80K

+13.32%

Dr. Marshall S. Stanton, M.D.

Senior Vice President, Clinical Research and Chief Medical Officer

48.71K

-45.78%

Mr. Matthew A. (Matt) Getz

Vice President - Human Resources

34.12K

-21.64%

名稱

名稱/職務

職務

持股

持股變動

Mr. John E. Davis

Senior Vice President - Global Sales and Marketing

188.49K

+7.55%

Mr. Daniel J. Bevevino

Independent Director

150.06K

+4.40%

Mr. Thomas F. Ackerman

Independent Director

149.90K

+4.41%

Ms. Amy D. Horton, CPA

Chief Accounting Officer, Vice President

142.38K

+6.92%

Mr. Jon W. Salveson

Independent Director

129.84K

+5.12%

Mr. Lance A. Berry, CPA

Chief Financial Officer, Executive Vice President - Finance

121.36K

+10.09%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

Aortic stent grafts

36.60M

36.98%

On X

21.57M

21.80%

Surgical sealants

18.11M

18.29%

Other

2.52M

2.54%

暫無數據

業務

地區

業務USD

名稱

營收

佔比

Aortic stent grafts

36.60M

36.98%

On X

21.57M

21.80%

Surgical sealants

18.11M

18.29%

Other

2.52M

2.54%

股東統計

更新時間: 5月17日週六

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.46%

Macquarie Investment Management

6.80%

Perceptive Advisors LLC

6.54%

Fidelity Management & Research Company LLC

6.51%

The Vanguard Group, Inc.

6.49%

Other

60.19%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.46%

Macquarie Investment Management

6.80%

Perceptive Advisors LLC

6.54%

Fidelity Management & Research Company LLC

6.51%

The Vanguard Group, Inc.

6.49%

Other

60.19%

股東類型

持股股東

佔比

Investment Advisor

57.95%

Investment Advisor/Hedge Fund

28.93%

Private Equity

6.54%

Individual Investor

5.25%

Hedge Fund

1.99%

Research Firm

1.20%

Pension Fund

1.06%

Bank and Trust

0.43%

Sovereign Wealth Fund

0.05%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

390

44.18M

103.45%

+2.14M

2025Q1

402

44.36M

103.89%

+1.66M

2024Q4

380

41.09M

97.75%

+880.04K

2024Q3

367

38.98M

93.02%

-790.24K

2024Q2

349

38.52M

92.17%

-784.32K

2024Q1

347

38.26M

91.68%

-2.02M

2023Q4

342

37.08M

90.20%

-1.57M

2023Q3

339

37.01M

90.02%

-1.95M

2023Q2

331

37.22M

87.77%

-1.77M

2023Q1

335

37.61M

88.87%

-1.51M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

5.75M

13.46%

-106.89K

-1.83%

Mar 31, 2025

Macquarie Investment Management

2.90M

6.8%

+166.78K

+6.09%

Mar 31, 2025

Perceptive Advisors LLC

2.79M

6.54%

--

Mar 31, 2025

Fidelity Management & Research Company LLC

2.78M

6.51%

+1.72M

+161.42%

Mar 31, 2025

The Vanguard Group, Inc.

2.77M

6.49%

-22.88K

-0.82%

Mar 31, 2025

Juniper Investment Company, LLC

2.10M

4.91%

--

Mar 31, 2025

Morgan Stanley Smith Barney LLC

1.94M

4.54%

-50.93K

-2.56%

Mar 31, 2025

Wellington Management Company, LLP

1.73M

4.05%

+67.33K

+4.06%

Mar 31, 2025

State Street Global Advisors (US)

1.53M

3.59%

-13.74K

-0.89%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

1.31M

3.07%

-160.12K

-10.87%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

AAM Sawgrass US Small Cap Quality Growth ETF

2.93%

Unusual Whales Subversive Democratic Trading ETF

2.48%

ROBO Global Healthcare Technology & Innovation ETF

1.7%

SPDR S&P Health Care Equipment ETF

1.64%

Invesco Dorsey Wright Healthcare Momentum ETF

1.53%

Invesco S&P SmallCap Health Care ETF

0.85%

Invesco S&P SmallCap 600 Pure Growth ETF

0.5%

First Trust Small Cap Growth AlphaDEX Fund

0.41%

Invesco S&P SmallCap Momentum ETF

0.39%

Invesco Dorsey Wright SmallCap Momentum ETF

0.37%

AAM Sawgrass US Small Cap Quality Growth ETF

佔比2.93%

Unusual Whales Subversive Democratic Trading ETF

佔比2.48%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.7%

SPDR S&P Health Care Equipment ETF

佔比1.64%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比1.53%

Invesco S&P SmallCap Health Care ETF

佔比0.85%

Invesco S&P SmallCap 600 Pure Growth ETF

佔比0.5%

First Trust Small Cap Growth AlphaDEX Fund

佔比0.41%

Invesco S&P SmallCap Momentum ETF

佔比0.39%

Invesco Dorsey Wright SmallCap Momentum ETF

佔比0.37%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Artivion Inc

31.880USD

Artivion Inc

31.880

概覽

公司

財務